Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tohru Ohnuma

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Geriatric Psychiatry|October 5, 2016
Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case-control studyYoshihide Takeshita, Nobuto Shibata, Koji Kasanuki, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 12, 2016
Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese PopulationAyako Suzuki, Nobuto Shibata, Koji Kasanuki, et al.
International Journal of Methods in Psychiatric Research|February 1, 2019
Skin advanced glycation end products as biomarkers of photosensitivity in schizophreniaEriko Tani, Tohru Ohnuma, Hitoki Hirose, et al.
Psychiatry Research|August 8, 2013
The possibility that requiring high-dose olanzapine cannot be explained by pharmacokinetics in the treatment of acute-phase schizophreniaKotaro Hatta, Hiroshi Takebayashi, Yasuhiko Sudo, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 11, 2012
No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophreniaMaiko Kitazawa, Tohru Ohnuma, Yuto Takebayashi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 11, 2017
High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophreniaTakahiro Sannohe, Tohru Ohnuma, Masayoshi Takeuchi, et al.
Neuroscience Letters|March 14, 2015
Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophreniaMayu Takeda, Tohru Ohnuma, Masayoshi Takeuchi, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 31, 2012
Functional genetic variation at the NRGN gene and schizophrenia: evidence from a gene-based case-control study and gene expression analysisKazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, et al.
Nature Communications|February 4, 2016
Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disordersTakanobu Nakazawa, Ryota Hashimoto, Kazuto Sakoori, et al.
Psychiatry and Clinical Neurosciences|November 4, 2016
Estimated cognitive decline in patients with schizophrenia: A multicenter studyHaruo Fujino, Chika Sumiyoshi, Yuka Yasuda, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Geriatric Psychiatry|October 5, 2016
Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case-control studyYoshihide Takeshita, Nobuto Shibata, Koji Kasanuki, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 12, 2016
Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese PopulationAyako Suzuki, Nobuto Shibata, Koji Kasanuki, et al.
International Journal of Methods in Psychiatric Research|February 1, 2019
Skin advanced glycation end products as biomarkers of photosensitivity in schizophreniaEriko Tani, Tohru Ohnuma, Hitoki Hirose, et al.
Psychiatry Research|August 8, 2013
The possibility that requiring high-dose olanzapine cannot be explained by pharmacokinetics in the treatment of acute-phase schizophreniaKotaro Hatta, Hiroshi Takebayashi, Yasuhiko Sudo, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 11, 2012
No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophreniaMaiko Kitazawa, Tohru Ohnuma, Yuto Takebayashi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 11, 2017
High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophreniaTakahiro Sannohe, Tohru Ohnuma, Masayoshi Takeuchi, et al.
Neuroscience Letters|March 14, 2015
Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophreniaMayu Takeda, Tohru Ohnuma, Masayoshi Takeuchi, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 31, 2012
Functional genetic variation at the NRGN gene and schizophrenia: evidence from a gene-based case-control study and gene expression analysisKazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, et al.
Nature Communications|February 4, 2016
Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disordersTakanobu Nakazawa, Ryota Hashimoto, Kazuto Sakoori, et al.
Psychiatry and Clinical Neurosciences|November 4, 2016
Estimated cognitive decline in patients with schizophrenia: A multicenter studyHaruo Fujino, Chika Sumiyoshi, Yuka Yasuda, et al.
Pageof 8